See the latest news and media coverage for Sanofi. We track all announcements, press releases, and industry mentions in real time, all in one place.
R&D-driven, AI-powered biopharmaceutical company
sanofi.comLast updated
In short: Sanofi raised its 2026 outlook following strong Q2 results, though shares fell as its new CEO initiated a strategic pipeline review.
Cheplapharm acquires 20 mature drugs and three manufacturing sites. Sanofi receives a 26.4% equity stake in the German company, facilitating transaction completion by Q3 2027.
The diverse lineup spans research, manufacturing, finance, and vaccines under Belén Garijo’s leadership.
The European Commission expanded the existing indication to include infants from six weeks, protecting against serogroups A, C, W, and Y.
Sales grew 17.8% CER, business EPS up 33.3%, and 2026 guidance upgraded.
Employees at the Sanofi company in Ploërmel (Morbihan) are sounding the alarm over the future of the site following the announcement of the sale to the German group...
Sanofi is divesting 20 older medicines to Cheplapharm as the drugmaker’s new chief executive officer seeks to focus the ...
The European Commission has authorized Germany to pay Sanofi 400 million euros to maintain insulin production in Frankfurt. In return, the laboratory will have to build...
Dupixent sales beat forecast, but worries persist over pipeline and patent expiryNew CEO Belén Garijo to outline growth strategy beyond DupixentSanofi...
Track Sanofi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Sanofi and other trending companies.